Evolution of methylphenidate prescriptions in the region of Occitanie, France, from 2013 to 2021
L'Encéphale · 2025
DOI: 10.1016/j.encep.2025.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift L'Encéphale, 2025. Verfasst von Aurélien Velay und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Saint-Eloi Hospital, University Medical Center of Montpellier, Montpellier, France. Electronic address…. Hauptthemen laut MEDLINE: Methylphenidate, Attention Deficit Disorder with Hyperactivity, Drug Prescriptions, Central Nervous System Stimulants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Insurance Administration.
Abstract (Originalsprache)
INTRODUCTION: Attention Deficit Hyperactivity Disorder (ADHD) is a frequent neurodevelopmental disorder with a lasting functional impact. Our objective was to analyze methylphenidate prescription rates between 2013 and 2021 in Occitanie, to study their evolution over time, disparities within the same region, and factors that could influence them. METHODS: Data were extracted via the national insurance health data system, the inter-regime consumption data mart of the Occitanie region. Prevalence and incidence data were reported based on population data from NISES within the same territories. Deprivation indices of municipalities and classification of territories according to rurality were used as analysis variables. RESULTS: Between 2013 and 2021, the overall rate of methylphenidate prescription in Occitanie increased by 97.3% with territorial disparities. In 2019, the prescription prevalence across all age groups studied was 0.19%, and the incidence was 0.06%. The abandonment rate represents 22.32% across all ages. The decrease in deliveries in the second quarter of 2020 coincides with the COVID-19 pandemic. CONCLUSION: Our data are consistent with the results observed at the national level, namely an increase in methylphenidate prescriptions of around 12% per year. Similar results are observed in countries using methylphenidate with initially low prescription rates. The level of prescription reached in Occitanie remains significantly lower than that of comparable Occidental countries, with significant territorial disparities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Child and Adolescent Psychiatry, Saint-Eloi Hospital, University Medical Center of Montpellier, Montpellier, France. Electronic address: aurelien.velay@gmail.com.
- Regional Direction of Occitanie Medical Services, National Health Insurance, Montpellier, France.
- Department of Child and Adolescent Psychiatry, Saint-Eloi Hospital, University Medical Center of Montpellier, Montpellier, France; Center of Epidemiology and Population Health, Inserm U1018-Developmental Psychiatry, Uni…
- Ambroise-Paré Medical Clinic, ELSAN, & Éventail 31 group, Toulouse, France; Occitadys, Toulouse, France; French Association of pediatrics (AFPA), Ancenis Saint-Géron, France.
Förderung
- National Health Insurance Administration
Zitieren
APA
Velay, A., Alexis, J., Papinaud, L., Domerg, C., Ouakil, D. P., Willig, T. N., & Kerbage, H. (2025). Evolution of methylphenidate prescriptions in the region of Occitanie, France, from 2013 to 2021. L'Encéphale. https://doi.org/10.1016/j.encep.2025.01.005
Vancouver
Velay A, Alexis J, Papinaud L, Domerg C, Ouakil DP, Willig TN, et al. Evolution of methylphenidate prescriptions in the region of Occitanie, France, from 2013 to 2021. L'Encéphale. 2025. doi:10.1016/j.encep.2025.01.005
BibTeX
@article{Velay2025,
author = {Velay, Aurélien and Alexis, Jennifer and Papinaud, Laurence and Domerg, Caroline and Ouakil, Diane Purper and Willig, Thiébaut-Noël and Kerbage, Hala},
title = {Evolution of methylphenidate prescriptions in the region of Occitanie, France, from 2013 to 2021},
journal = {L'Encéphale},
year = {2025},
doi = {10.1016/j.encep.2025.01.005}
}
EUVIMED